Subcutaneous Fat Clinical Trial
Official title:
A Randomized, Placebo-Controlled, Phase 2b Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
This is a randomized, placebo-controlled, Phase 2b study to evaluate the efficacy, safety, and tolerability of CBL-514 injection for reducing subcutaneous fat.
A total of approximately 110 adult participants with moderate or severe abdominal fat as assessed by the Investigator via live evaluation using the Clinician-Reported Abdominal Fat Rating Scale (CR-AFRS) at Screening will be enrolled. Each participant will receive up to 4 treatments of allocated CBL-514 (2 mg/cm²) or placebo administered subcutaneously to the abdomen, once every 3 weeks. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04699669 -
A Phase 1 Study to Evaluate the Safety and Tolerability of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02512822 -
Usefulness of Non-invasive Radiofrequency Therapy for Facial Contouring
|
N/A | |
Active, not recruiting |
NCT06005441 -
A Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat.
|
Phase 2 | |
Not yet recruiting |
NCT03160976 -
Cryolipolysis on Localized Adiposity
|
N/A | |
Completed |
NCT03871556 -
Diagnostic Ultrasound for Measuring Fat of the Body
|
N/A | |
Completed |
NCT02098811 -
Evaluation of the Safety and Precursors of Efficacy
|
N/A | |
Active, not recruiting |
NCT04553627 -
Feasibility of Producing the Appearance of a Gluteal Lift Post Cryolipolysis
|
N/A | |
Completed |
NCT02539043 -
Effects of Ultrasound Cavitation Focused on Located Adiposity
|
N/A | |
Completed |
NCT01842802 -
Clinical Investigation of Non Invasive Fat Reduction
|
N/A | |
Completed |
NCT04698642 -
A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CBL-514 Injection for Reducing Convexity or Fullness of Abdominal Subcutaneous Fat
|
Phase 2 | |
Completed |
NCT02052622 -
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
|
Phase 3 | |
Completed |
NCT04897412 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2)
|
Phase 2 | |
Completed |
NCT03682471 -
Long-term 24-month Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 (Sodium Deoxycholate Injection)
|
||
Completed |
NCT05234736 -
A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers
|
Phase 2 | |
Completed |
NCT04575467 -
A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1)
|
Phase 2 |